Transition metal complex containing sulfonamide or amide group for olefin metathesis reaction and application thereof

US10933409B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10933409-B2
Application numberUS-201716072192-A
CountryUS
Kind codeB2
Filing dateJan 25, 2017
Priority dateFeb 1, 2016
Publication dateMar 2, 2021
Grant dateMar 2, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed is a novel transition metal complex containing N-heterocyclic carbene and a sulfonamide group, or N-heterocyclic carbene and an amide group, and application thereof, the traquesnsition metal complex having a wider range of general purposes in olefin metathesis and being able to be variably controlled in reactivity.

First claim

Opening claim text (preview).

The invention claimed is: 1. A transition metal complex, represented by the following Chemical Formula A: (L1)M(B)(L2) n (L3) m   [Chemical Formula A] wherein, M is a transition metal of ruthenium, L1 means a phosphine ligand or N-heterocyclic carbene ligand containing a substituted or unsubstituted alkyl of 1 to 30 carbon atoms or a substituted or unsubstituted aryl of 6 to 30 carbon atoms, L2 and L3, which are the same or different, are each a monovalent ligand selected from among a hydrogen atom, a deuterium atom, a halogen, a cyano, a substituted or unsubstituted alkyl of 1 to 30 carbon atoms, a substituted or unsubstituted aryl of 6 to 50 carbon atoms, a substituted or unsubstituted arylalkyl of 7 to 50 carbon atoms, a substituted or unsubstituted alkenyl of 2 to 30 carbon atoms, a substituted or unsubstituted alkynyl of 2 to 20 carbon atoms, a substituted or unsubstituted cycloalkyl of 3 to 30 carbon atoms, a substituted or unsubstituted cycloalkenyl of 5 to 30 carbon atoms, a substituted or unsubstituted alkoxy of 1 to 30 carbon atoms, a substituted or unsubstituted aryloxy of 6 to 30 carbon atoms, a substituted or unsubstituted arylthioxy of 6 to 30 carbon atoms, a substituted or unsubstituted alkylthioxy of 1 to 30 carbon atoms, a substituted or unsubstituted heteroaryl of 2 to 50 carbon atoms bearing O, N, or S as a heteroatom, a substituted or unsubstituted carboxylate anion of 1 to 30 carbon atoms, and a nitrate (NO3-); or a neutral ligand selected from among a phosphine containing a substituted or unsubstituted alkyl of 1 to 30 carbon atoms or a substituted or unsubstituted aryl of 6 to 50 carbon atoms, carbon monoxide, an amine containing a substituted or unsubstituted alkyl of 1 to 30 carbon atoms or a substituted or unsubstituted aryl of 6 to 50 carbon atoms, a nitrile containing a substituted or unsubstituted alkyl of 1 to 30 carbon atoms or a substituted or unsubstituted aryl of 6 to 50 carbon atoms, and a substituted or unsubstituted aromatic heterocyclic compound of 2 to 50 carbon atoms bearing O, N, or S as a heteroatom; in the alterative for L2 and L3, L2 and L3 are connected to each other to form a ring with M, and when L2 and L3 are each plural, the corresponding plural L2's or L3's are connected to each other to form a ring with M, n and m, which are the same or different, are each independently an integer of 0 to 2 and when n or m is 2 or greater, the corresponding plural L2's or L3's are the same or different, and A is a ligand represented by the following Structural Formula A-1 or A-2: wherein, R11 to R13, which are the same or different, are each independently selected from among a hydrogen atom, a deuterium atom, a substituted or unsubstituted alkyl of 1 to 30 carbon atoms, a substituted or unsubstituted 7 aryl of 6 to 50 carbon atoms, a substituted or unsubstituted cycloalkyl of 3 to 30 carbon atoms, a substituted or unsubstituted heteroaryl of 2 to 50 carbon atoms bearing at least one selected from among O, N, S, and Si as a heteroatom, a substituted or unsubstituted alkoxy of 1 to 30 carbon atoms, a substituted or unsubstituted aryloxy of 6 to 30 carbon atoms, a substituted or unsubstituted alkylamine of 1 to 30 carbon atoms, a substituted or unsubstituted aryl amine of 6 to 30 carbon atoms, a substituted or unsubstituted alkylsilyl of 1 to 30 carbon atoms, a substituted or unsubstituted arylsilyl of 6 to 30 carbon atoms, a cyano, and a halogen, and ‘..’ means a pair of electrons of carbene. 2. The transition metal complex of claim 1 , wherein L2 and L3, which are the same or different, are each independently a halogen selected from among F, Cl, Br and I, and n and m are each an integer of 1 in Chemical Formula A. 3. The transition metal complex of claim 1 , wherein the N-heterocyclic carbene ligand is represented by the following Chemical Formula B: wherein X1 is selected from among O, S, N-R2, C-R3, and C-R4R5, a single or a double bond is between X1 and Y1, between Y1 and Y2, and between Y2 and Y3, Y1 to Y3, which are the same or different, are each independently selected from among N, N-R6, C-R7, and C-R8R9, m is an integer of 0 to 3, and when m is 2 or greater, the corresponding plural Y2's are the same or different, with a single or a double bond therebetween, R1 to R9, which are the same or different, are each independently selected from among a hydrogen atom, a deuterium atom, a halogen, a substituted or unsubstituted alkyl of 1 to 30 carbon atoms, a substituted or unsubstituted aryl of 6 to 50 carbon atoms, a substituted or unsubstituted arylalkyl of 7 to 50 carbon atoms, a substituted or unsubstituted cycloalkyl of 3 to 30 carbon atoms, a substituted or unsubstituted alkoxy of 1 to 30 carbon atoms, a substituted or unsubstituted aryloxy of 6 to 30 carbon atoms, and a substituted or unsubstituted heteroaryl of 2 to 50 carbon atoms bearing O, N, or S as a heteroatom, with a proviso that R1 and R2 are each neither a hydrogen atom nor a deuterium atom, and ‘..’ means a pair of electrons in carbene. 4. The transition metal complex of claim 3 , wherein the N-heterocyclic carbene ligand is one selected from among Chemical Formulas B-1 to B-13: wherein R1 and R2 are each as defined above, R′ is selected from among a hydrogen atom, a deuterium atom, a halogen, a substituted or unsubstituted alkyl of 1 to 30 carbon atoms, a substituted or unsubstituted aryl of 6 to 50 carbon atoms, a substituted or unsubstituted arylalkyl of 7 to 50 carbon atoms, a substituted or unsubstituted cycloalkyl of 3 to 30 carbon atoms, a substituted or unsubstituted alkoxy of 1 to 30 carbon atoms, a substituted or unsubstituted aryloxy of 6 to 30 carbon atoms, a substituted or unsubstituted heteroaryl of 2 to 50 carbon atoms bearing O, N, or S as a heteroatom, n is an integer of 1 to 8, and when plural R's exist in one molecule, R's are the same or different. 5. The transition metal complex of claim 4 , wherein the N-heterocyclic carbene is one selected from among the following Chemical Formulas B-20 to B-37: 6. The transition metal complex of claim 1 , wherein an oxygen atom and a carbon atom of the carbene moiety in Structural Formulas A-1 and A-2 are bound to the transition metal. 7. The transition metal complex of claim 1 , wherein at least one of the substituents R11 to R13 contains a fluorine atom. 8. A method for conducting an olefin metathesis reaction, comprising using the transition metal complex of claim 1 . 9. The method of claim 8 , wherein the metathesis reaction is a ring-closing metathesis reaction. 10. A catalyst for olefin metathesis, prepared by supporting the transition metal complex of claim 1 on a carrier.

Assignees

Inventors

Classifications

  • Cobalt compounds · CPC title

  • Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton · CPC title

  • containing coordination complexes · CPC title

  • Anionic ligands, i.e. the overall ligand carries at least one formal negative charge · CPC title

  • by isomerisation; by change of size of the carbon skeleton (introduction or elimination of carboxyl groups C07C67/313, C07C67/32) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10933409B2 cover?
Disclosed is a novel transition metal complex containing N-heterocyclic carbene and a sulfonamide group, or N-heterocyclic carbene and an amide group, and application thereof, the traquesnsition metal complex having a wider range of general purposes in olefin metathesis and being able to be variably controlled in reactivity.
Who is the assignee on this patent?
Seoul Nat Univ R&Db Foundation
What technology area does this patent fall under?
Primary CPC classification B01J31/2278. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Mar 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).